Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (191-200 of 285) with videos related to

Pageof 29
Sort By:
Journal of the National Cancer Institute|January 2, 2017
Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin ASuman K Samanta, Anuradha Sehrawat, Su-Hyeong Kim, et al.
Oncology Nursing Forum|October 31, 2014
Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptomsG J van Londen, Heidi S Donovan, Ellen B Beckjord, et al.
Breast Cancer Research and Treatment|May 2, 2012
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studyLawrence J Solin, Robert Gray, Lori J Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Reply to C. Shah et alLawrence J Solin, Robert Gray, Lorie L Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 StudyLawrence J Solin, Robert Gray, Lorie L Hughes, et al.
Journal of the National Cancer Institute|December 6, 2011
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteriaEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 21, 2015
Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after ParturitionTiffany A Katz, Serena G Liao, Vincent J Palmieri, et al.
Cell Reports. Medicine|September 20, 2025
Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblastsNao Nishida-Aoki, Songli Zhu, Marina Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateHarold J Burstein, Sarah Temin, Holly Anderson, et al.
Pageof 29

Showing results (191-200 of 285) with videos related to

Sort By:
Pageof 29
Journal of the National Cancer Institute|January 2, 2017
Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin ASuman K Samanta, Anuradha Sehrawat, Su-Hyeong Kim, et al.
Oncology Nursing Forum|October 31, 2014
Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptomsG J van Londen, Heidi S Donovan, Ellen B Beckjord, et al.
Breast Cancer Research and Treatment|May 2, 2012
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studyLawrence J Solin, Robert Gray, Lori J Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Reply to C. Shah et alLawrence J Solin, Robert Gray, Lorie L Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 StudyLawrence J Solin, Robert Gray, Lorie L Hughes, et al.
Journal of the National Cancer Institute|December 6, 2011
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteriaEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 21, 2015
Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after ParturitionTiffany A Katz, Serena G Liao, Vincent J Palmieri, et al.
Cell Reports. Medicine|September 20, 2025
Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblastsNao Nishida-Aoki, Songli Zhu, Marina Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateHarold J Burstein, Sarah Temin, Holly Anderson, et al.
Pageof 29